PLoS ONE (Jan 2015)

Serological and Progression Differences of Joint Destruction in the Wrist and the Feet in Rheumatoid Arthritis - A Cross-Sectional Cohort Study.

  • Yosuke Hamamoto,
  • Hiromu Ito,
  • Moritoshi Furu,
  • Motomu Hashimoto,
  • Takao Fujii,
  • Masahiro Ishikawa,
  • Noriyuki Yamakawa,
  • Chikashi Terao,
  • Masayuki Azukizawa,
  • Takahiro Iwata,
  • Tsuneyo Mimori,
  • Shuichi Matsuda

DOI
https://doi.org/10.1371/journal.pone.0136611
Journal volume & issue
Vol. 10, no. 8
p. e0136611

Abstract

Read online

To investigate clinical and radiological differences between joint destruction in the wrist and the feet in patients with RA.A cross-sectional clinical study was conducted in an RA cohort at a single institution. Clinical data included age, sex and duration of disease. Laboratory data included sero-positivity for anti-cyclic citrullinated peptide (CCP) antibody and RF. Radiological measurements included Larsen grades and the modified Sharp/van der Heijde method (SHS) for the hands/wrists and the feet. Statistical analyses were performed using the Kruskal-Wallis H-test, a dummy variable linear regression model and multivariate logistic regression analysis with 95% confidence interval and odds ratios.A total of 405 patients were enrolled, and 314 patients were analysed in this study. The duration of disease in the foot-dominant group was significantly less than that in the wrist-dominant group. When patients were subdivided by duration of disease, the Larsen grade of the feet was significantly higher than that of the wrist in the first quadrant subgroup, but this was reversed with increasing duration of disease. Anti-CCP status was a significant predictive factor for joint destruction in the wrist but not in the feet, while RF status was not predictive in either the wrist or the feet.Joint destruction in the feet started earlier than in the wrist, but the latter progresses faster with increasing duration of disease. Anti-CCP status predicts joint destruction in the wrist better than in the feet.